Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.

Link-Gelles R, Weber ZA, Reese SE, Payne AB, Gaglani M, Adams K, Kharbanda AB, Natarajan K, DeSilva MB, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Embi PJ, Dunne MM, Dickerson M, McEvoy C, Arndorfer J, Naleway AL, Goddard K, Dixon BE, Griggs EP, Hansen J, Valvi N, Najdowski M, Timbol J, Rogerson C, Fireman B, Fadel WF, Patel P, Ray CS, Wiegand R, Ball S, Tenforde MW

Open source

DOI
10.15585/mmwr.mm7221a3
Published
2023 May 26
Container
MMWR. Morbidity and mortality weekly report
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15585/mmwr.mm7221a3,
  title = {Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.},
  author = {Link-Gelles R and Weber ZA and Reese SE and Payne AB and Gaglani M and Adams K and Kharbanda AB and Natarajan K and DeSilva MB and Dascomb K and Irving SA and Klein NP and Grannis SJ and Ong TC and Embi PJ and Dunne MM and Dickerson M and McEvoy C and Arndorfer J and Naleway AL and Goddard K and Dixon BE and Griggs EP and Hansen J and Valvi N and Najdowski M and Timbol J and Rogerson C and Fireman B and Fadel WF and Patel P and Ray CS and Wiegand R and Ball S and Tenforde MW},
  year = {2023},
  journal = {MMWR. Morbidity and mortality weekly report},
  doi = {10.15585/mmwr.mm7221a3},
  url = {https://doi.org/10.15585/mmwr.mm7221a3}
}

RIS

TY  - JOUR
TI  - Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
AU  - Link-Gelles R
AU  - Weber ZA
AU  - Reese SE
AU  - Payne AB
AU  - Gaglani M
AU  - Adams K
AU  - Kharbanda AB
AU  - Natarajan K
AU  - DeSilva MB
AU  - Dascomb K
AU  - Irving SA
AU  - Klein NP
AU  - Grannis SJ
AU  - Ong TC
AU  - Embi PJ
AU  - Dunne MM
AU  - Dickerson M
AU  - McEvoy C
AU  - Arndorfer J
AU  - Naleway AL
AU  - Goddard K
AU  - Dixon BE
AU  - Griggs EP
AU  - Hansen J
AU  - Valvi N
AU  - Najdowski M
AU  - Timbol J
AU  - Rogerson C
AU  - Fireman B
AU  - Fadel WF
AU  - Patel P
AU  - Ray CS
AU  - Wiegand R
AU  - Ball S
AU  - Tenforde MW
PY  - 2023
JO  - MMWR. Morbidity and mortality weekly report
DO  - 10.15585/mmwr.mm7221a3
UR  - https://doi.org/10.15585/mmwr.mm7221a3
ER  - 

APA

R, L., ZA, W., SE, R., AB, P., M, G., K, A., AB, K., K, N., MB, D., K, D., SA, I., NP, K., SJ, G., TC, O., PJ, E., MM, D., M, D., C, M., J, A., AL, N., K, G., BE, D., EP, G., J, H., N, V., M, N., J, T., C, R., B, F., WF, F., P, P., CS, R., R, W., S, B., & MW, T. (2023). Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.. MMWR. Morbidity and mortality weekly report. https://doi.org/10.15585/mmwr.mm7221a3

Source records